Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12606000225516
Ethics application status
Not yet submitted
Date submitted
21/05/2006
Date registered
5/06/2006
Date last updated
5/06/2006
Type of registration
Prospectively registered
Titles & IDs
Public title
Does the design of the Proseal reduce the incidence of gastro-oesophageal reflux?
Query!
Scientific title
Comparison of the incidence of gastro-oesophageal reflux with the ProSeal laryngeal mask airway in spontaneous ventilating verses controlled ventilating patients undergoing general anaesthesia for elective surgery.
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Gastro-oesophageal Reflux (GOR)
1203
0
Query!
Condition category
Condition code
Anaesthesiology
1287
1287
0
0
Query!
Other anaesthesiology
Query!
Oral and Gastrointestinal
1288
1288
0
0
Query!
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The laryngeal mask airway (LMA) is used for management of the airway during general anaesthesia. A limiting factor with the use of the laryngeal mask airway (LMA) is the lack of airway protection from regurgitated gastric contents.
The ProSeal laryngeal mask airway (PLMA) has a double cuff design resulting in a higher airway seal pressure and an independent drain tube that opens at the upper oesophageal sphincter. The higher airway seal pressure allows the administration of Intermittent positive pressure ventilation (IPPV) without gas leakage. We propose to insert a pH catheter into the oesophagus via the independent drainage tube of the ProSeal laryngeal mask airway (PLMA) to look for changes in pH indicating gastro oesophageal reflux (GOR) during general anaesthesia.
Patients presenting for elective surgery which does not require paralysis or tracheal intubation will be invited to participate in the study.
Forty patients will be randomly assigned to one of two groups, spontaneous ventilation(SV) or intermittent positive pressure ventilation (IPPV).
The pH catheter will remain insitu for the duration of the surgery. At the completion of the case the patient will be woken and the pH catheter and ProSeal laryngeal mask airway (PLMA) removed.
Query!
Intervention code [1]
1061
0
Diagnosis / Prognosis
Query!
Comparator / control treatment
Spontaneous ventilation(SV)
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
1748
0
A gastro oesophageal reflux (GOR) episode is defined as a decrease in pH to less than 4.
A Zinetics 24ME multi-use pH catheter will be advanced through the drainage port of the Proseal laryngeal mask airway (PLMA). The electrode will be advanced into the stomach which will be confirmed by pH levels of less the 3. It will then be slowly withdrawn to the gastro-oesophageal junction, the site being indicated by an abrupt increase in the pH recorded to levels above 5. It will then be withdrawn a further 4-5cm to be positioned at the mid-oesophagus.
The probe will be connected to a Digitrapper 100 pH monitoring device which records oesophageal pH every 4 seconds.
At the completion of the case the patient will be woken and the pH catheter and ProSeal laryngeal mask airway (PLMA) removed.
Query!
Assessment method [1]
1748
0
Query!
Timepoint [1]
1748
0
Oesophageal pH will be measured throughout the duration of the surgery, every 4 seconds, from the point of insertion of the probe at the beginning of the case until the removal of the probe at the completion of the surgery.
Query!
Primary outcome [2]
1749
0
Age will be compared using the unpaired t-test.
Query!
Assessment method [2]
1749
0
Query!
Timepoint [2]
1749
0
Measured at the beginning of surgery.
Query!
Primary outcome [3]
1750
0
Body Mass Index (BMI) will be compared using the unpaired t-test.
BMI is a measure of persons height scaled to their weight. BMI = weight in kilograms divided by height in meters squared.
Query!
Assessment method [3]
1750
0
Query!
Timepoint [3]
1750
0
Measured at the beginning of surgery.
Query!
Primary outcome [4]
1751
0
Duration of anaesthesia will be compared using the unpaired t-test.
Query!
Assessment method [4]
1751
0
Query!
Timepoint [4]
1751
0
Query!
Primary outcome [5]
1752
0
Duration of surgery is a value in minutes and varies with the type of surgery and skill of the operator.
Query!
Assessment method [5]
1752
0
Query!
Timepoint [5]
1752
0
Query!
Primary outcome [6]
1753
0
A gastro oesophageal reflux (GOR) episode is defined as a decrease in pH to less than 4. pH will be sampled every 4 seconds for the duration of the case. Therefore a pH measure of less than 4 during the case = an episode of reflux.
The incidence of reflux will be analysed using Fisher’s exact test. Using a predicted incidence of gastro oesophageal reflux (GOR) of 30% and 5% in the intermittent positive pressure ventilation (IPPV) and spontaneous breathing patients respectively, power analysis suggests that a sample size of 30 patients for each group will be adequate to have an 80% chance of detecting a statistically significant difference. A p value of less than 0.05 will be taken as statistically significant.
Query!
Assessment method [6]
1753
0
Query!
Timepoint [6]
1753
0
Query!
Secondary outcome [1]
3102
0
No secondary outcomes
Query!
Assessment method [1]
3102
0
Query!
Timepoint [1]
3102
0
Query!
Eligibility
Key inclusion criteria
Patients presenting for elective surgery.- Male and female- Healthy or only mild systemic illness (American Society of Anesthesiologists [ASA] grade I or II).
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
Not stated
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Unable or decline to give consent- Patient in prone position for surgery- Body mass index > 30kg.m-3- Pre-existing pH or gastric anatomical problemso History of GORo Receiving medications that might effect pH or motilityo Previous upper gastro intestinal surgeryo Hiatus hernia.
Query!
Study design
Purpose of the study
Diagnosis
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Coin-tossing
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Query!
Type of endpoint/s
Safety
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
20/06/2006
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
60
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
1414
0
Commercial sector/Industry
Query!
Name [1]
1414
0
LMA PacMed
Query!
Address [1]
1414
0
Query!
Country [1]
1414
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Dr Anil Sen Gupta
Query!
Address
Query!
Country
Query!
Secondary sponsor category [1]
1240
0
None
Query!
Name [1]
1240
0
Nil
Query!
Address [1]
1240
0
Query!
Country [1]
1240
0
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Summary
Brief summary
On arrival to the anaesthetic room patients will have non-invasive monitoring established and a venous access line placed under local anaesthesia prior to induction of general anaesthesia. Following pre-oxygenation of the patient, induction of anaesthesia will be carried out by the anaesthetist in charge of the case. Intravenous fentanyl (2mcg.kg-1), followed by an induction dose of propofol (1-3mg.kg-1) will be given. The patients allocated to the IPPV group will be given intravenous rocuronium (0.6mg.kg-1). Once an adequate depth of anaesthesia has been reached a ProSeal laryngeal mask airway (PLMA) will be inserted as per the manufactures recommended technique. Anaesthesia will be maintained on 2% sevoflurane in 0.5 litre.min-1 oxygen and 1 litre.min-1 nitrous oxide for both spontaneous breathing and intermittent positive pressure ventilation (IPPV) patients. Intermittent positive pressure ventilation (IPPV) will be delivered with a tidal volume of 10ml.kg-1 and a respiratory rate of 8-14 breaths per minute. A Zinetics 24ME multi-use pH catheter with external reference electrode will then be advanced through the drainage port of the ProSeal laryngeal mask airway (PLMA). The electrode will be advanced into the stomach which will be confirmed by pH levels of less the 3. It will then be slowly withdrawn to the gastro-oesophageal junction, the site being indicated by an abrupt increase in the pH recorded to levels above 5. It will then be withdrawn a further 4-5cm to be positioned at the mid-oesophagus. At the completion of the case the patient will be woken and the pH catheter and ProSeal laryngeal mask airway (PLMA) removed. The investigator will be blinded to all pH measurements following the insertion of the catheter. The recording will be subsequently transferred to a computer to be analysed with Polygram 98 Diagnostic Workstation software by an investigator blinded to the anaesthetic technique.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
35253
0
Query!
Address
35253
0
Query!
Country
35253
0
Query!
Phone
35253
0
Query!
Fax
35253
0
Query!
Email
35253
0
Query!
Contact person for public queries
Name
10250
0
Dr Anil Sen Gupta
Query!
Address
10250
0
Department of Anaesthetics
Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050
Query!
Country
10250
0
Australia
Query!
Phone
10250
0
+61 2 95158564
Query!
Fax
10250
0
+61 2 95192455
Query!
Email
10250
0
[email protected]
Query!
Contact person for scientific queries
Name
1178
0
Dr Anil Sen Gupta
Query!
Address
1178
0
Department of Anaesthetics
Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050
Query!
Country
1178
0
Australia
Query!
Phone
1178
0
+61 2 95158564
Query!
Fax
1178
0
+61 2 95192455
Query!
Email
1178
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF